Literature DB >> 2402441

Synthesis and applications of oligoribonucleotides with selected 2'-O-methylation using the 2'-O-[1-(2-fluorophenyl)-4-methoxypiperidin-4-yl] protecting group.

B Beijer1, I Sulston, B S Sproat, P Rider, A I Lamond, P Neuner.   

Abstract

The synthesis of base protected 5'-O-dimethoxytrityl-2'-O-[1-(2- fluorophenyl)-4-methoxypiperidin-4-yl]-3'-O-(2-cyanoethyl N,N-diisopropylphosphoramidites) is described, using phenoxyacetyl protection for the exocyclic amino groups of guanosine and adenosine and acetyl protection of the amino group of cytidine. High yield assembly of these building blocks into oligoribonucleotides on aminopropyl controlled pore glass was achieved using 5-(4-nitrophenyl)-1H-tetrazole as activator. Mixed sequences containing selected 2'-O-methylation were also synthesised and their significance for the study of RNA biochemistry is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2402441      PMCID: PMC332135          DOI: 10.1093/nar/18.17.5143

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  Polymer-supported RNA synthesis and its application to test the nearest-neighbor model for duplex stability.

Authors:  R Kierzek; M H Caruthers; C E Longfellow; D Swinton; D H Turner; S M Freier
Journal:  Biochemistry       Date:  1986-12-02       Impact factor: 3.162

2.  Solid phase synthesis of oligoribonucleotides using the o-nitrobenzyl group for 2'-hydroxyl protection and H-phosphonate chemistry.

Authors:  T Tanaka; S Tamatsukuri; M Ikehara
Journal:  Nucleic Acids Res       Date:  1987-09-25       Impact factor: 16.971

3.  Improved chemistry for oligodeoxyribonucleotide synthesis substantially improves restriction enzyme cleavage of a synthetic 35mer.

Authors:  I K Farrance; J S Eadie; R Ivarie
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

4.  Enzymatic synthesis of RNA oligonucleotides.

Authors:  L Sharmeen; J Taylor
Journal:  Nucleic Acids Res       Date:  1987-08-25       Impact factor: 16.971

5.  Solid phase synthesis of oligoribonucleotides using o-nitrobenzyl protection of 2'-hydroxyl via a phosphite triester approach.

Authors:  T Tanaka; S Tamatsukuri; M Ikehara
Journal:  Nucleic Acids Res       Date:  1986-08-11       Impact factor: 16.971

6.  Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates.

Authors:  J F Milligan; D R Groebe; G W Witherell; O C Uhlenbeck
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

7.  5'-Levulinyl and 2'-tetrahydrofuranyl protection for the synthesis of oligoribonucleotides by the phosphoramidite approach.

Authors:  S Iwai; E Ohtsuka
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

8.  Action of acid on oligoribonucleotide phosphotriester intermediates. Effect of released vicinal hydroxy functions.

Authors:  C B Reese; P A Skone
Journal:  Nucleic Acids Res       Date:  1985-07-25       Impact factor: 16.971

9.  A new solid-phase synthesis of oligoribonucleotides by the phosphoro-p-anisidate method using tetrahydrofuranyl protection of 2'-hydroxyl groups.

Authors:  S Iwai; E Yamada; M Asaka; Y Hayase; H Inoue; E Ohtsuka
Journal:  Nucleic Acids Res       Date:  1987-05-11       Impact factor: 16.971

10.  The final deprotection step in oligonucleotide synthesis is reduced to a mild and rapid ammonia treatment by using labile base-protecting groups.

Authors:  J C Schulhof; D Molko; R Teoule
Journal:  Nucleic Acids Res       Date:  1987-01-26       Impact factor: 16.971

View more
  9 in total

1.  A simple procedure for the preparation of protected 2'-O-methyl or 2'-O-ethyl ribonucleoside-3'-O-phosphoramidites.

Authors:  E Wagner; B Oberhauser; A Holzner; H Brunar; G Issakides; G Schaffner; M Cotten; M Knollmüller; C R Noe
Journal:  Nucleic Acids Res       Date:  1991-11-11       Impact factor: 16.971

2.  A self-assembling short oligonucleotide duplex suitable for pretargeting.

Authors:  Prabodhika Mallikaratchy; Jeffery Gardner; Lars Ulrik R Nordstrøm; Nicholas J Veomett; Michael R McDevitt; Mark L Heaney; David A Scheinberg
Journal:  Nucleic Acid Ther       Date:  2013-07-13       Impact factor: 5.486

3.  Preparation of oligoribonucleotides containing 4-thiouridine using Fpmp chemistry. Photo-crosslinking to RNA binding proteins using 350 nm irradiation.

Authors:  A McGregor; M V Rao; G Duckworth; P G Stockley; B A Connolly
Journal:  Nucleic Acids Res       Date:  1996-08-15       Impact factor: 16.971

4.  Evaluation of 2'-hydroxyl protection in RNA-synthesis using the H-phosphonate approach.

Authors:  E Rozners; E Westman; R Strömberg
Journal:  Nucleic Acids Res       Date:  1994-01-11       Impact factor: 16.971

5.  2'-O-methyl, 2'-O-ethyl oligoribonucleotides and phosphorothioate oligodeoxyribonucleotides as inhibitors of the in vitro U7 snRNP-dependent mRNA processing event.

Authors:  M Cotten; B Oberhauser; H Brunar; A Holzner; G Issakides; C R Noe; G Schaffner; E Wagner; M L Birnstiel
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

6.  Use of the 1-(2-fluorophenyl)-4-methoxypiperidin-4-yl (Fpmp) and related protecting groups in oligoribonucleotide synthesis: stability of internucleotide linkages to aqueous acid.

Authors:  D C Capaldi; C B Reese
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

7.  In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1.

Authors:  K Rittner; C Burmester; G Sczakiel
Journal:  Nucleic Acids Res       Date:  1993-03-25       Impact factor: 16.971

8.  Function of specific 2'-hydroxyl groups of guanosines in a hammerhead ribozyme probed by 2' modifications.

Authors:  D M Williams; W A Pieken; F Eckstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

9.  Nuclease resistant ribozymes with high catalytic activity.

Authors:  G Paolella; B S Sproat; A I Lamond
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.